Characteristics of the breast tumors
. | N (%) . | |
---|---|---|
Infiltrating carcinomas | 103 | |
Histologic type | ||
Ductal | 97 (94.2) | |
Lobular | 6 (5.8) | |
Histologic grade | ||
1 | 3 (2.9) | |
2 | 56 (54.4) | |
3 | 44 (42.7) | |
pT | ||
1 | 33 (32.0) | |
2 | 64 (62.2) | |
3 | 6 (5.8) | |
pN | ||
0 | 50 (48.5) | |
1 | 37 (35.9) | |
2 | 6 (5.8) | |
3 | 10 (9.8) | |
Hormone receptors | ||
ER/PR+ | 75 (72.8) | |
HER2/neu | ||
Overexpression | 23 (22.3) | |
Amplification | 21 (20.4) | |
Ki67 (MIB1) | ||
>20% | 29 (28.2) | |
≤20% | 74 (71.8) |
. | N (%) . | |
---|---|---|
Infiltrating carcinomas | 103 | |
Histologic type | ||
Ductal | 97 (94.2) | |
Lobular | 6 (5.8) | |
Histologic grade | ||
1 | 3 (2.9) | |
2 | 56 (54.4) | |
3 | 44 (42.7) | |
pT | ||
1 | 33 (32.0) | |
2 | 64 (62.2) | |
3 | 6 (5.8) | |
pN | ||
0 | 50 (48.5) | |
1 | 37 (35.9) | |
2 | 6 (5.8) | |
3 | 10 (9.8) | |
Hormone receptors | ||
ER/PR+ | 75 (72.8) | |
HER2/neu | ||
Overexpression | 23 (22.3) | |
Amplification | 21 (20.4) | |
Ki67 (MIB1) | ||
>20% | 29 (28.2) | |
≤20% | 74 (71.8) |